Colin Hill Biography

In his professional career Colin is currently the Chairman of the Board of Fina Technologies a subsidiary of Via Science and Chairman and CEO of GNS Healthcare a leading healthcare analytics company that matches drugs to patients in clinical trials and in patient care.
A valued supporter of Accelerated Cure Project Colin has helped to make introductions that have opened many doors for us and increased our understanding of how data-oriented approaches and technologies such as those developed by GNS can contribute to curing complex diseases like MS. He believes that technology combined with ACP’s data resources could significantly advance research findings in MS.
Colin serves on the boards of the New York Foundation for Science Technology and Innovation (NYSTAR) and of a biopharmaceutical company dedicated to the development of a new treatment for sickle cell disease. In 2004 he was named to MIT Technology Review‘s TR100 list of the world’s top innovators under the age of 35. He graduated with a degree in physics from Virginia Tech and earned master’s degrees in physics from McGill University and Cornell University.

As a renowned expert and highly sought-after speaker, Colin Hill's expertise is in high demand. To book Colin Hill for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure Colin Hill's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with Colin Hill's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing Colin Hill for your next speaking engagement.